Skip to content

Clinical trials

Phase 2 Substance Withdrawal Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Substance Withdrawal Syndrome Phase: Phase 2 Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20071
20081
20091
20171
20181
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status2
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dalhousie University1
Evon Medics LLC1
IRCCS Azienda Ospedaliero-Universitaria di Bologna1
Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente1
Jed E. Rose1
Masaryk University1
Sydney South West Area Health Service1
University Hospital, Clermont-Ferrand1
University of Calgary1
University of Memphis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Substance Withdrawal Syndrome12
Chronic Pain2
Marijuana Abuse2
Opioid-Related Disorders2
Agnosia1
Anxiety Disorders1
Leukemia, Myeloid, Chronic-Phase1
Lymphoma, Follicular1
Substance-Related Disorders1

Trials

Showing 51 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.